Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 3/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.43 |
| ▸ | HPSE | Q9Y251 | 11/20 | 0.41 |
| ▸ | BDNF | P23560 | 3/20 | 0.39 |
| ▸ | PTN | P21246 | 2/20 | 0.39 |
| ▸ | MDK | P21741 | 2/20 | 0.39 |
| ▸ | PF4 | P02776 | 1/20 | 0.38 |
| ▸ | AMY2A | P04746 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30043156 | 0.95 | F10 (0.48) | F10F2SERPINC1HPSEAMY2A | |
| SCHEMBL29358293 | 0.91 | F10 (0.56) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL29352252 | 0.91 | F10 (0.56) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL15395277 | 0.91 | F10 (0.57) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL29647566 | 0.90 | F10 (0.60) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL29361154 | 0.89 | F10 (0.52) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL12300300 | 0.88 | F10 (0.63) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL30041224 | 0.88 | F10 (0.64) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL12514116 | 0.88 | F10 (0.52) | F10F2SERPINC1HPSEBDNF | |
| SCHEMBL15395242 | 0.87 | F10 (0.44) | F10F2SERPINC1HPSEPF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120020798-A | Simulation method of multipurpose electromagnetic pulse simulator | 广电计量检测（西安）有限公司 | 2025-05-20 | — | — | CN | claimed |
| CN-114994792-B | On-line metal detection self-correcting device | 福建恒安集团有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-115895763-B | Ether-based lubricant compositions, methods and uses | 卡斯特罗尔有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118202023-A | Polypropylene viscosity modifier and lubricating oil thereof | 埃克森美孚化学专利公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118159055-A | Organic light-emitting layer, organic electroluminescent device, and electronic device | 华为终端有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-108359008-B | Use of anti-CGRP or anti-CGRP-R antibodies or antibody fragments for the treatment or prevention of chronic and acute forms of diarrhea | H.伦德贝克公司 | 2022-03-29 | — | — | CN | claimed |
| WO-2026098336-A1 | WELL-SEISMIC FUSION FULL-FREQUENCY INVERSION METHOD AND APPARATUS | 中国石油天然气集团有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-121570591-B | Mesoporous core-shell structure nano-enzyme with multienzyme activity and preparation method and application thereof | 深圳大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-122013078-A | Method for improving corrosion fatigue performance of aluminum and/or magnesium alloy by combining laser shot blasting with peak aging and aluminum and/or magnesium alloy finished product | 中国人民解放军空军工程大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-121570591-A | Mesoporous core-shell structure nano-enzyme with multienzyme activity and preparation method and application thereof | 深圳大学 | 2026-02-27 | — | — | CN | disclosed |
| US-20250368996-A1 | MODIFIED ANTISENSE OLIGONUCLEOTIDES FOR TREATING HEPATITIS B VIRUS | ALIGOS THERAPEUTICS, INC. (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250263461-A1 | RECOMBINANT T-CELL RECEPTORS THAT BIND THE NY-ESO-1 AND/OR LAGE-1A CANCER ANTIGENS | T-CURE BIOSCIENCE, INC. | 2025-08-21 | — | — | US | disclosed |
| CN-120008419-B | Composite bulletproof armor layered structure and preparation method thereof | 上海铠福防护科技有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-108359008-B | Use of anti-CGRP or anti-CGRP-R antibodies or antibody fragments for the treatment or prevention of chronic and acute forms of diarrhea | H.伦德贝克公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-110678328-B | Decorative multi-layer extrusion blow-molded bottle | 东洋制罐株式会社 | 2022-03-22 | — | — | CN | disclosed |
| CN-110678328-B | Decorative multi-layer extrusion blow-molded bottle | 东洋制罐株式会社 | 2022-03-22 | — | — | CN | disclosed |
| CN-108373502-B | anti-CGRP compositions and uses thereof | H.伦德贝克公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114088313-A | Method for continuously measuring radon exhalation rate by changing leakage coefficient and anti-diffusion coefficient | 衡阳师范学院 | 2022-02-25 | — | — | CN | disclosed |
| WO-2022039243-A1 | APPLICATOR | 三菱鉛筆株式会社 | 2022-02-24 | — | — | WO | disclosed |
| CN-114058954-A | High-strength fastener for marine atmosphere and humid environment bridge | 洛阳双瑞特种装备有限公司 | 2022-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368996-A1 | MODIFIED ANTISENSE OLIGONUCLEOTIDES FOR TREATING HEPATITIS B VIRUS | HAVCR2, SNRPB2, NSUN2 | F10 4761/4885F2 4846/4885SERPINC1 1245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.